Tomorrow Capital, a Mumbai based $100 million venture capital fund, has exited from further investments in ZenoHealth (a generic medicine startup earlier known as Generico) to focus on other early stage investment opportunities.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
